A phase II trial of the aurora kinase A inhibitor MLN8237 in patients with metastatic castrate resistant and neuroendocrine prostate cancer.
Himisha Beltran
Research Funding - Millennium
Mark A. Rubin
No relevant relationships to disclose
Juan Miguel Mosquera
No relevant relationships to disclose
Paul J. Christos
No relevant relationships to disclose
Olivera Calukovic
No relevant relationships to disclose
Irene Karpenko
No relevant relationships to disclose
Jacek K. Pinski
No relevant relationships to disclose
Daniel Costin Danila
No relevant relationships to disclose
David M. Nanus
No relevant relationships to disclose
Scott T. Tagawa
No relevant relationships to disclose